1-7 of 7
Harry Hollema
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity

Marthe M. de Jonge, Lauren L. Ritterhouse, Cornelis D. de Kroon, Maaike P.G. Vreeswijk, Jeremy P. Segal, Rutika Puranik, Harry Hollema, Matti A. Rookus, Christi J. van Asperen, Flora E. van Leeuwen, Vincent T.H.B.M. Smit, Brooke E. Howitt, Tjalling Bosse
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (24): 7517–7526.
https://doi.org/10.1158/1078-0432.CCR-19-0848
Published: 13 December 2019
View article titled, Germline <em>BRCA</em>-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
Open the PDF for Germline <em>BRCA</em>-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity in another window
Includes: Supplementary data
Journal Articles

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

Mariëtte I.E. van Poelgeest, Marij J.P. Welters, Renee Vermeij, Linda F.M. Stynenbosch, Nikki M. Loof, Dorien M.A. Berends-van der Meer, Margriet J.G. Löwik, Ineke L.E. Hamming, Edith M.G. van Esch, Bart W.J. Hellebrekers, Marc van Beurden, Henk W. Schreuder, Marjolein J. Kagie, J. Baptist M.Z. Trimbos, Lorraine M. Fathers, Toos Daemen, Harry Hollema, A. Rob P.M. Valentijn, Jaap Oostendorp, J. Hanneke N.G. Oude Elberink, Gertjan J. Fleuren, Tjalling Bosse, Gemma G. Kenter, Theo Stijnen, Hans W. Nijman, Cornelis J.M. Melief, Sjoerd H. van der Burg
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (10): 2342–2350.
https://doi.org/10.1158/1078-0432.CCR-15-2594
Published: 12 May 2016
View article titled, Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
Open the PDF for Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response in another window
Includes: Supplementary data
Journal Articles

Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer

Maartje C.A. Wouters, Fenne L. Komdeur, Hagma H. Workel, Harry G. Klip, Annechien Plat, Neeltje M. Kooi, G. Bea A. Wisman, Marian J.E. Mourits, Henriette J.G. Arts, Maaike H.M. Oonk, Refika Yigit, Steven de Jong, Cornelis J.M. Melief, Harry Hollema, Evelien W. Duiker, Toos Daemen, Marco de Bruyn, Hans W. Nijman
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (3): 714–724.
https://doi.org/10.1158/1078-0432.CCR-15-1617
Published: 31 January 2016
View article titled, Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer
Open the PDF for Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer

Maartje G. Noordhuis, Rudolf S.N. Fehrmann, G. Bea A. Wisman, Esther R. Nijhuis, Jelmer J. van Zanden, Perry D. Moerland, Emiel Ver Loren van Themaat, Haukeline H. Volders, Mirjam Kok, Klaske A. ten Hoor, Harry Hollema, Elisabeth G.E. de Vries, Geertruida H. de Bock, Ate G.J. van der Zee, Ed Schuuring
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (6): 1317–1330.
https://doi.org/10.1158/1078-0432.CCR-10-2320
Published: 15 March 2011
View article titled, Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer
Open the PDF for Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer in another window
Includes: Supplementary data
Journal Articles

Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer

Maartje G. Noordhuis, Jasper J.H. Eijsink, Klaske A. ten Hoor, Frank Roossink, Harry Hollema, Henriëtte J.G. Arts, Elisabeth Pras, John H. Maduro, Anna K.L. Reyners, Geertruida H. de Bock, G. Bea A. Wisman, Ed Schuuring, Ate G.J. van der Zee
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7389–7397.
https://doi.org/10.1158/1078-0432.CCR-09-1149
Published: 30 November 2009
View article titled, Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer
Open the PDF for Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer in another window
Includes: Supplementary data
Journal Articles

Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model

Evelien W. Duiker, Elisabeth G.E. de Vries, Devalingam Mahalingam, Gert Jan Meersma, Wytske Boersma-van Ek, Harry Hollema, Marjolijn N. Lub-de Hooge, Go M. van Dam, Robbert H. Cool, Wim J. Quax, Afshin Samali, Ate G.J. van der Zee, Steven de Jong
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (6): 2048–2057.
https://doi.org/10.1158/1078-0432.CCR-08-1535
Published: 16 March 2009
View article titled, Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model
Open the PDF for Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model in another window
Includes: Supplementary data
Journal Articles

Population Pharmacokinetics and Pharmacodynamics of Paclitaxel and Carboplatin in Ovarian Cancer Patients: A Study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group

Markus Joerger, Alwin D.R. Huitema, Dick J. Richel, Christian Dittrich, Nikolas Pavlidis, Evangelos Briasoulis, Jan B. Vermorken, Elena Strocchi, Andrea Martoni, Roberto Sorio, Henk P. Sleeboom, Miguel A. Izquierdo, Duncan I. Jodrell, Hilary Calvert, Alan V. Boddy, Harry Hollema, Regine Féty, Wjf J.F. Van der Vijgh, Georg Hempel, Etienne Chatelut, Mats Karlsson, Justin Wilkins, Brigitte Tranchand, Ad H.G.J. Schrijvers, Christian Twelves, Jos H. Beijnen, Jan H.M. Schellens
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (21): 6410–6418.
https://doi.org/10.1158/1078-0432.CCR-07-0064
Published: 01 November 2007
View article titled, Population Pharmacokinetics and Pharmacodynamics of Paclitaxel and Carboplatin in Ovarian Cancer Patients: A Study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group
Open the PDF for Population Pharmacokinetics and Pharmacodynamics of Paclitaxel and Carboplatin in Ovarian Cancer Patients: A Study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group in another window